1. Home
  2. Analysis
  3. Fragmin
  4. Systemic-lupus-erythematosus

Fragmin and Systemic lupus erythematosus - a phase IV clinical study of FDA data

Summary:

Systemic lupus erythematosus is reported as a side effect among people who take Fragmin (dalteparin sodium), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Bactrim, and have Antiphospholipid syndrome.

The phase IV clinical study analyzes which people have Systemic lupus erythematosus when taking Fragmin. It is created by eHealthMe based on reports of 11,893 people who have side effects when taking Fragmin from the FDA, and is updated regularly.

What is Fragmin?

Fragmin has active ingredients of dalteparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 11,999 Fragmin users. Check the latest studies of Fragmin.

What is Systemic lupus erythematosus?

Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) is found to be associated with 1,087 drugs and 1,646 conditions by eHealthMe. Check the latest studies of Systemic lupus erythematosus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

11,893 people reported to have side effects when taking Fragmin.
Among them, 12 people (0.1%) have Systemic lupus erythematosus.

Could Fragmin cause Systemic lupus erythematosus?

Among these 12 people:

How long have people been on Fragmin when they have Systemic lupus erythematosus? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Systemic lupus erythematosus when taking Fragmin? *

  • female: 100 %
  • male: 0.0 %

What is the age of people who have Systemic lupus erythematosus when taking Fragmin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 55.56 %
  • 40-49: 44.44 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Fragmin? *

  1. Crestor: 4 people, 33.33%
  2. Potassium: 4 people, 33.33%
  3. Cellcept: 4 people, 33.33%
  4. Magnesium: 4 people, 33.33%
  5. Carafate: 4 people, 33.33%
  6. Nexium: 4 people, 33.33%
  7. Bactrim: 4 people, 33.33%
  8. Cardizem: 2 people, 16.67%
  9. Lasix: 2 people, 16.67%
  10. Dilaudid: 2 people, 16.67%

What are other side effects people have besides Systemic lupus erythematosus? *

  1. Rashes (redness): 5 people, 41.67%
  2. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 5 people, 41.67%
  3. Bleeding Disorders: 4 people, 33.33%
  4. Fatigue (feeling of tiredness): 3 people, 25.00%
  5. Fever: 2 people, 16.67%
  6. Infusion Site Pain: 2 people, 16.67%
  7. Weight Decreased: 2 people, 16.67%
  8. Infusion Site Erythema (reddening of the skin at infusion site): 2 people, 16.67%
  9. Hypoaesthesia (reduced sense of touch or sensation): 2 people, 16.67%
  10. Haematoma (collection of blood outside the blood vessels): 2 people, 16.67%

What are the existing conditions these people have? *

  1. Antiphospholipid Syndrome (disorder that manifests clinically as recurrent venous or arterial thrombosis and/or fetal loss): 5 people, 41.67%
  2. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 16.67%
  3. Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 2 people, 16.67%
  4. Abscess (pus): 2 people, 16.67%
  5. Pneumonia: 1 person, 8.33%
  6. Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
  7. Essential Hypertension (primary hypertension): 1 person, 8.33%
  8. Embolism Venous (embolus may pass into the arterial system): 1 person, 8.33%
  9. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Fragmin and have Systemic lupus erythematosus?

- Check whether Systemic lupus erythematosus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fragmin:

Systemic lupus erythematosus treatments and more:

How severe was Systemic lupus erythematosus and when was it recovered:

Expand to all the drugs that have ingredients of dalteparin sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fragmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Systemic lupus erythematosus:

Browse all the conditions that are associated with Systemic lupus erythematosus:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on dalteparin sodium (the active ingredients of Fragmin) and Fragmin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.